Document is current
Any future updates will be listed below
-
Authors
Cooper, Chris E. https://orcid.org/0000-0003-0381-3990
Simons, Michelle
Dyson, Alex https://orcid.org/0000-0001-8334-9432
Leiva Eriksson, Nélida
Silkstone, Gary G. A.
Syrett, Natalie
Allen-Baume, Victoria
Bülow, Leif
Ronda, Luca https://orcid.org/0000-0002-5389-2669
Mozzarelli, Andrea https://orcid.org/0000-0003-3762-0062
Singer, Mervyn https://orcid.org/0000-0002-1042-6350
Reeder, Brandon J. https://orcid.org/0000-0001-7474-2611
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/L01310X/1)
RCUK | MRC | Medical Research Foundation (MR/L01310X/1)
- License Information
-
More Information
Article History
Received: 6 February 2024
Revised: 9 July 2024
Accepted: 16 July 2024
First Online: 1 October 2024
Competing interests
: C.E.C. and B.J.R. have patents granted and pending related to the modification of hemoglobin amino acids designed to enhance the performance of an oxygen therapeutic.
